ВИПАДОК РІДКІСНОЇ МУТАЦІЇ CASR, ПОВ’ЯЗАНОЇ З HER2-ПОЗИТИВНИМ РАКОМ ГРУДНОЇ ЗАЛОЗИ

• Datum: 2026
• Автори та афіліації: N. Kitsera — Lviv Oncology Regional Treatment and Diagnostic Center, Lviv, Ukraine; Ya. Shparyk — Lviv Oncology Regional Treatment and Diagnostic Center, Lviv, Ukraine; I. Duda — Lviv Oncology Regional Treatment and Diagnostic Center, Lviv, Ukraine; Yu. Mylyan — Lviv Oncology Regional Treatment and Diagnostic Center, Lviv, Ukraine; N. Kunta — Danylo Halytskyi Lviv National Medical University, Lviv, Ukraine
• Ключові слова: keywords
• Hauptverfasser: Kitsera, N., Shparyk, Ya., Duda, I., Mylyan, Yu., Kunta, N.
• Format: Artikel
• Sprache: Englisch
• Veröffentlicht: PH Akademperiodyka 2026
• Online Zugang: https://exp-oncology.com.ua/index.php/Exp/article/view/620
• Назва журналу: Experimental Oncology

Although highly penetrant genes such as BRCA1, BRCA2, TP53, PALB2, CHEK2, and ATM are well known in hereditary breast cancer, genes with low penetrance may also contribute to the disease risk. The CASR (Calcium-Sensing Receptor) gene, located on chromosome 3q13.3–q21, encodes a G-protein-coupled rec...